112 related articles for article (PubMed ID: 1244415)
1. Inhibition of lymphocyte trapping by a passenger virus in murine ascitic tumors: characterization of lactic dehydrogenase virus (LDV) as the inhibitory component and analysis of the mechanism of inhibition.
Mongini PK; Rosenberg LT
J Exp Med; 1976 Jan; 143(1):100-13. PubMed ID: 1244415
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of lymphocyte trapping by cell-free ascitic fluids cultivated in syngeneic mice.
Mongini PK; Rosenberg LT
J Immunol; 1975 Feb; 114(2 Pt 1):650-4. PubMed ID: 1120902
[TBL] [Abstract][Full Text] [Related]
3. Effect of lactic dehydrogenase virus infection on tumor induction and tumor growth.
Isakov N; Feldman M; Segal S
Cancer Res; 1981 Feb; 41(2):667-72. PubMed ID: 7448812
[TBL] [Abstract][Full Text] [Related]
4. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
McDonald TL
J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive activity of a subline of the mouse EL-4 lymphoma. Evidence for minute virus of mice causing the inhibition.
Bonnard GD; Manders EK; Campbell DA; Herberman RB; Collins MJ
J Exp Med; 1976 Jan; 143(1):187-205. PubMed ID: 1244418
[TBL] [Abstract][Full Text] [Related]
6. Purification and electron microscopy of lactic dehydrogenase virus of mice.
Horzinek MC; Wielink PS
J Gen Virol; 1975 Mar; 26(3):217-26. PubMed ID: 47383
[TBL] [Abstract][Full Text] [Related]
7. Effect of silica on virus infections in mice and mouse tissue culture.
duBuy H
Infect Immun; 1975 May; 11(5):996-1002. PubMed ID: 164415
[TBL] [Abstract][Full Text] [Related]
8. Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses.
Onyekaba CO; Harty JT; Even C; Hu BG; Plagemann PG
Virus Res; 1989 Dec; 14(4):297-315. PubMed ID: 2623944
[TBL] [Abstract][Full Text] [Related]
9. A tumor-associated lactic dehydrogenase virus suppresses the host resistance to infection with Listeria monocytogenes.
Isakov N; Segal S
Immunobiology; 1983 May; 164(5):402-16. PubMed ID: 6873999
[TBL] [Abstract][Full Text] [Related]
10. Lactate dehydrogenase-elevating virus replication persists in liver, spleen, lymph node, and testis tissues and results in accumulation of viral RNA in germinal centers, concomitant with polyclonal activation of B cells.
Anderson GW; Rowland RR; Palmer GA; Even C; Plagemann PG
J Virol; 1995 Aug; 69(8):5177-85. PubMed ID: 7609091
[TBL] [Abstract][Full Text] [Related]
11. Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity.
van den Broek MF; Spörri R; Even C; Plagemann PG; Hänseler E; Hengartner H; Zinkernagel RM
J Immunol; 1997 Aug; 159(4):1585-8. PubMed ID: 9257815
[TBL] [Abstract][Full Text] [Related]
12. Immunodepression, ascites tumour and lactate dehydrogenase virus.
Vincent MD; Potter JG; Cooper S
S Afr Med J; 1977 Nov; 52(23):924-6. PubMed ID: 594855
[TBL] [Abstract][Full Text] [Related]
13. Lack of correlation of growth attenuation of murine lymphoma caused by in vitro passage with loss of lactate dehydrogenase virus.
Johnson RJ; Shin HS
J Natl Cancer Inst; 1983 Dec; 71(6):1337-41. PubMed ID: 6581366
[TBL] [Abstract][Full Text] [Related]
14. Lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of macrophages yet fails to affect their phagocytic activity.
Isakov N; Feldman M; Segal S
Immunobiology; 1982; 162(1):15-27. PubMed ID: 7106838
[TBL] [Abstract][Full Text] [Related]
15. Lactic dehydrogenase virus alteration of lymphocyte circulation.
Mongini PK; Rosenberg LT
J Immunol; 1978 Feb; 120(2):459-62. PubMed ID: 621389
[TBL] [Abstract][Full Text] [Related]
16. Ia antigens and Fc receptors of mouse peritoneal macrophages as determinants of susceptibility to lactic dehydrogenase virus.
Inada T; Mims CA
J Gen Virol; 1985 Jul; 66 ( Pt 7)():1469-77. PubMed ID: 3860626
[TBL] [Abstract][Full Text] [Related]
17. Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation.
Rowland RR; Even C; Anderson GW; Chen Z; Hu B; Plagemann PG
J Gen Virol; 1994 May; 75 ( Pt 5)():1071-81. PubMed ID: 8176369
[TBL] [Abstract][Full Text] [Related]
18. Transplacental lactate dehydrogenase-elevating virus (LDV) transmission: immune inhibition of umbilical cord infection, and correlation of fetal virus susceptibility with development of F4/80 antigen expression.
Zitterkopf NL; Haven TR; Huela M; Bradley DS; Cafruny WA
Placenta; 2002 May; 23(5):438-46. PubMed ID: 12061860
[TBL] [Abstract][Full Text] [Related]
19. Immune complexes that bind to ELISA plates not coated with antigen in mice infected with lactate dehydrogenase-elevating virus: relationship to IgG2a- and IgG2b-specific polyclonal activation of B cells.
Hu B; Even C; Plagemann PG
Viral Immunol; 1992; 5(1):27-38. PubMed ID: 1610489
[TBL] [Abstract][Full Text] [Related]
20. Polyclonal B cell activation of IgG2a and IgG2b production by infection of mice with lactate dehydrogenase-elevating virus is partly dependent on CD4+ lymphocytes.
Li X; Hu B; Harty J; Even C; Plagemann PG
Viral Immunol; 1990; 3(4):273-88. PubMed ID: 2076177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
